135 related articles for article (PubMed ID: 23358476)
21. Mammaglobin-based strategies for treatment of breast cancer.
Goedegebuure PS; Watson MA; Viehl CT; Fleming TP
Curr Cancer Drug Targets; 2004 Sep; 4(6):531-42. PubMed ID: 15462037
[TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer.
Carter D; Douglass JF; Cornellison CD; Retter MW; Johnson JC; Bennington AA; Fleming TP; Reed SG; Houghton RL; Diamond DL; Vedvick TS
Biochemistry; 2002 May; 41(21):6714-22. PubMed ID: 12022875
[TBL] [Abstract][Full Text] [Related]
23. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA.
Zach O; Kasparu H; Krieger O; Hehenwarter W; Girschikofsky M; Lutz D
J Clin Oncol; 1999 Jul; 17(7):2015-9. PubMed ID: 10561252
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the utility of trefoil factor 1 as a mammary-specific immunostain compared and in conjunction with GATA-3 and mammaglobin in the distinction between carcinoma of breast and lung.
Wells JM; Ginter PS; Liu Y; Chen Z; Narula N; Shin SJ
Am J Clin Pathol; 2015 Sep; 144(3):444-51. PubMed ID: 26276775
[TBL] [Abstract][Full Text] [Related]
25. Mammaglobin as a marker for the detection of tumor cells in the peripheral blood of breast cancer patients.
Zach O; Kasparu H; Wagner H; Krieger O; Lutz D
Ann N Y Acad Sci; 2000; 923():343-5. PubMed ID: 11193775
[No Abstract] [Full Text] [Related]
26. Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer.
Bitisik O; Saip P; Saglam S; Derin D; Dalay N
Genet Mol Res; 2010; 9(1):97-106. PubMed ID: 20092039
[TBL] [Abstract][Full Text] [Related]
27. The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers.
Lin YC; Wu Chou YH; Liao IC; Cheng AJ
Cancer Lett; 2003 Feb; 191(1):93-9. PubMed ID: 12609714
[TBL] [Abstract][Full Text] [Related]
28. Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer.
Plumer A; Duan H; Subramaniam S; Lucas FL; Miesfeldt S; Ng AK; Liaw L
BMC Cancer; 2008 Jan; 8():38. PubMed ID: 18237408
[TBL] [Abstract][Full Text] [Related]
29. Mammaglobin as a diagnostic serum marker of complex canine mammary carcinomas.
Pandey M; Kumar BV; Verma R
Res Vet Sci; 2015 Dec; 103():187-92. PubMed ID: 26679816
[TBL] [Abstract][Full Text] [Related]
30. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
31. New look inside human breast ducts with Raman imaging. Raman candidates as diagnostic markers for breast cancer prognosis: Mammaglobin, palmitic acid and sphingomyelin.
Abramczyk H; Brozek-Pluska B
Anal Chim Acta; 2016 Feb; 909():91-100. PubMed ID: 26851089
[TBL] [Abstract][Full Text] [Related]
32. Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer.
Jaramillo A; Majumder K; Manna PP; Fleming TP; Doherty G; Dipersio JF; Mohanakumar T
Int J Cancer; 2002 Dec; 102(5):499-506. PubMed ID: 12432553
[TBL] [Abstract][Full Text] [Related]
33. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
Kumar JK; Aronsson AC; Pilko G; Zupan M; Kumer K; Fabjan T; Osredkar J; Eriksson S
Tumour Biol; 2016 Sep; 37(9):11937-11945. PubMed ID: 27079872
[TBL] [Abstract][Full Text] [Related]
34. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer.
Fleming TP; Watson MA
Ann N Y Acad Sci; 2000; 923():78-89. PubMed ID: 11193781
[TBL] [Abstract][Full Text] [Related]
35. Serum antibodies to lipophilin B detected in late stage breast cancer patients.
Carter D; Dillon DC; Reynolds LD; Retter MW; Fanger G; Molesh DA; Sleath PR; McNeill PD; Vedvick TS; Reed SG; Persing DH; Houghton RL
Clin Cancer Res; 2003 Feb; 9(2):749-54. PubMed ID: 12576445
[TBL] [Abstract][Full Text] [Related]
36. Mammaglobin: a candidate diagnostic marker for breast cancer.
Zehentner BK; Carter D
Clin Biochem; 2004 Apr; 37(4):249-57. PubMed ID: 15003725
[TBL] [Abstract][Full Text] [Related]
37. Detection of human mammaglobin A mRNA in peripheral blood of breast cancer patients before treatment and association with metastasis.
Aristizábal-Pachón AF; de Carvalho TI; Carrara HH; de Andrade JM; Takahashi CS
J Egypt Natl Canc Inst; 2015 Dec; 27(4):217-22. PubMed ID: 26490322
[TBL] [Abstract][Full Text] [Related]
38. Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patients.
Radwan WM; Moussa HS; Essa ES; Kandil SH; Kamel AM
Asia Pac J Clin Oncol; 2013 Mar; 9(1):66-70. PubMed ID: 22897908
[TBL] [Abstract][Full Text] [Related]
39. Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer.
Jamidi SK; Hu J; Aphivatanasiri C; Tsang JY; Poon IK; Li JJ; Chan SK; Cheung SY; Tse GM
Histopathology; 2020 Dec; 77(6):936-948. PubMed ID: 32304249
[TBL] [Abstract][Full Text] [Related]
40. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer.
Watson MA; Fleming TP
Cancer Res; 1996 Feb; 56(4):860-5. PubMed ID: 8631025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
